Skip to content

Income Tax at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$70M-26.3%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$15.14M-250%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$6.37M+13.5%
TEC
Bio-TechneTECH
$20.18M+28.6%
Azenta logo
AzentaAZTA
-$323K-104%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$151K-193%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's income tax?
Ginkgo Bioworks (DNA) reported income tax of -$80K in Q1 2026.
How has Ginkgo Bioworks's income tax changed year-over-year?
Ginkgo Bioworks's income tax decreased by 190.9% year-over-year, from $88K to -$80K.
What is the long-term trend for Ginkgo Bioworks's income tax?
Over 4 years (2021 to 2025), Ginkgo Bioworks's income tax has grown at a -13.3% compound annual growth rate (CAGR), from -$1.48M to -$837K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.